Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients

Breast Cancer Research and Treatment

Volumn 151, Issue 3, 2015, Pages 679-686

  Hollen, Patricia J ^a   Msaouel, Pavlos ^b   Gralla, Richard J ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

BCSS; Breast cancer; Content validity; Quality of life evaluation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANXIETY; ARM SWELLING; ARTICLE; BODY IMAGE; BREAST CANCER; BREAST CANCER SYMPTOM SCALE QUESTIONNAIRE; BREAST DISEASE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CLIMACTERIUM; COMPUTER PROGRAM; CONTENT VALIDITY; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DISTRESS SYNDROME; DYSPNEA; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED PRACTICE; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH CARE NEED; HEALTH SURVEY; HOT FLUSH; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONSET AGE; OUTCOME ASSESSMENT; PAIN; PARTIAL MASTECTOMY; PATIENT REPORT OUTCOME; PHYSICAL EXAMINATION; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUALITY; SLEEP DISORDER; SLEEP PATTERN; SOCIAL PSYCHOLOGY; SYMPTOM; VAGINAL DRYNESS; BREAST NEOPLASMS; METASTASIS; RECURRENT DISEASE; RISK FACTOR; SELF REPORT; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; RECURRENCE; RISK FACTORS; SELF REPORT; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84930273909     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3420-5     Document Type: Article

References (14)

1. PROQOLID (Patient-reported Outcome and Quality of Life Instruments Database). Available at http://www.proqolid.org/. Accessed 21 Jan 2014
2. US Department of Health and Human Services (USDHHS); Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims (December 2009). Available at http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed 21 Jan 2014
3. Nunnally JC, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York
4. Hollen PJ, Gralla RJ, Kris MG, Potanovich LM (1993) Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 29A(Suppl 1):S51–58
5. Hollen PJ, Gralla RJ, Kris MG, Cox C, Belani CP, Grunberg SM, Crawford J, Neidhart JA (1994) Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73:2087–2098
6. Gralla RJ, Hollen PJ, Msaouel P, Davis BV, Petersen J (2014) An evidence-based determination of issues affecting quality of life and patient-reported outcomes in lung cancer: results of a survey of 660 patients. J Thorac Oncol 9:1243–1248
7. Sledge GW, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK, Wood WC (2003) Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol 21:588–592
8. R Development Core Team (2012) R: A language and environment for statistical computing. In: R Foundation for Statistical Computing, Vienna
9. Gralla RJ, Hollen PJ, Symanowski JT, Msaouel P, Kohn N, Lesser M (2014) Improving clinical prognostic categories beyond performance status: enhancing accuracy in survival prediction with a three-item patient-reported outcome (PRO) index from the LCSS in lung cancer and mesothelioma. J Clin Oncol 32:suppl; abstr 8065
10. Hollen PJ, Gralla RJ, Kris MG, Cox C (1994) Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 2:213–222
11. Hollen PJ, Gralla RJ, Liepa AM, Symanowski JT, Rusthoven JJ (2006) Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso. Support Care Cancer 14:11–21
12. Hollen PJ, Gralla RJ, Liepa AM, Symanowski JT, Rusthoven JJ (2004) Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validation. Cancer 101:587–595
13. Symanowski JT, Gralla RJ, Hollen PJ (2014) Enhancing accurate prediction of survival outcomes and aiding decision making in malignant pleural mesothelioma (MPM) using a three-item index from the LCSS-meso PRO measure: Results from a randomized 444 patient (pt) prospective trial. J Clin Oncol 32:suppl; abstr 7588
14. Hollen PJ, Gralla RJ, Stewart JA, Meharchand JM, Wierzbicki R, Leighl N (2013) Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL). Support Care Cancer 21:165–172